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Serotonin (5-HT) and leptin play important roles in the
modulation of energy balance. Here we investigated
mechanisms by which leptin might interact with CNS
5-HT pathways to influence appetite. Although some
leptin receptor (LepRb) neurons lie close to 5-HT
neurons in the dorsal raphe (DR), 5-HT neurons do
not express LepRb. Indeed, while leptin hyperpolar-
izes some non-5-HT DR neurons, leptin does not
alter the activity of DR 5-HT neurons. Furthermore,
5-HT depletion does not impair the anorectic effects
of leptin. The serotonin transporter-cre allele (Sertcre)
is expressed in 5-HT (and developmentally in some
non-5-HT) neurons. While Sertcre promotes LepRb
excision in a few LepRb neurons in the hypothal-
amus, it is not active in DR LepRb neurons, and
neuron-specific Sertcre-mediated LepRb inactivation
inmice does not alter bodyweight or adiposity. Thus,
leptin does not directly influence 5-HT neurons and
does not meaningfully modulate important appe-
tite-related determinants via 5-HT neuron function.
INTRODUCTION
Leptin, a hormone secreted by adipocytes in proportion to fat
mass, acts via the long form of the leptin receptor (LepRb) to
regulate energy homeostasis (Myers et al., 2009). Neuronal-
specific deletion of LepR promotes hyperphagia and obesity
(Cohen et al., 2001), and restoration of neuronal LepRb in
LepR-deficient mice normalizes food intake and body weight
(de Luca et al., 2005), indicating that leptin’s effects on energy
balance are achieved via brain LepRb.584 Cell Metabolism 13, 584–591, May 4, 2011 ª2011 Elsevier Inc.Within the brain, multiple populations of LepRb-expressing
neurons that contribute to energy homeostasis have been
identified, including (1) neurons of the hypothalamic arcuate
nucleus (ARC) that express pro-opiomelanocortin (POMC) or
agouti-related peptide (AgRP) (Balthasar et al., 2004; van de
Wall et al., 2008), (2) SF1-expressing neurons of the ventromedial
nucleus of the hypothalamus (Dhillon et al., 2006), (3) dopami-
nergic neurons in the ventral tegmental area (Fulton et al.,
2006; Hommel et al., 2006), (4) GABAergic neurons of the lateral
hypothalamic area (LHA) (Leinninger et al., 2009), and (5) neurons
within the nucleus of the solitary tract (Hayes et al., 2009), among
others (Myers et al., 2009; Patterson et al., 2011; Scott et al.,
2009).
Leptin also acts in concert with the brain serotonin (5-HT)
pathways, although important discrepancies exist regarding
the mechanisms underlying this interaction. A variety of data
suggest that leptin and 5-HT function independently but
converge in the ARC, although recent publications report a role
for direct leptin action via brain 5-HT neurons (Calapai et al.,
1999; Harris et al., 1998; von Meyenburg et al., 2003; Yadav
et al., 2009, 2011; Yamada et al., 2003). We thus generated
and utilized several mouse lines to resolve these issues and
clarify the potential role for 5-HT neurons in leptin action.RESULTS AND DISCUSSION
Distinct Localization of LepRb and 5-HT in CNS
Analysis using a LepRb riboprobe (Elmquist et al., 1998) revealed
that, with the exception of the dorsal raphe nucleus (DR),
brain regions containing 5-HT do not express Leprb mRNA
in the rat (see Figures S1A–S1F0 available online) or mouse
(Figures S1G–S1L0). Similarly, utilizing LepRbEGFP mice (Patter-
son et al., 2011), we observed no colocalization of LepRb
with 5-HT in the DR (Figures 1A and 1A0, and Figure S1). In
contrast, most DR neurons containing calbindin (Calb), a marker
Figure 1. Brain LepRb Neurons Do Not Contain 5-HT and Leptin Treatment Does Not Induce LepRb Signaling in 5-HT Neurons
(A) LepRb (green), as detected by GFP-IR, was not colocalized with 5-HT (red) in the DR of LepRbEGFP mice. (B) In contrast, DR LepRb neurons (green) also
expressed Calb-IR (red) in LepRbEGFP mice. Accordingly, leptin-induced pSTAT3 (green) was not detected in DR 5-HT neurons (red) in rats (C) treated with 1 mg/
kg leptin i.v., or wild-type mice (D) treated with 3 mg/kg leptin i.p. Leptin-induced pSTAT3 (green) was present in calbindin neurons (red) in rats (E) and wild-type
mice (F). (A0 )–(F0) aremagnifications of the boxed areas in (A)–(F) respectively. Scale bar in (F), 200 mmalso applies to (A)–(E). Scale bar in (F0), 50 mmalso applies to
(A0)–(E0). Arrowheads indicate dual-labeled cells. See also Figure S1.
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previously reported, a small population of DR dopamine (DA)
neurons also expressed LepRb (Figures S1M and S1M0) (Scott
et al., 2009).
We also assayed leptin-induced STAT3 phosphorylation
(pSTAT3), which is directly mediated by activated LepRb, to
examine direct leptin action in the midbrain. Leptin-induced
pSTAT3 was absent from all 5-HT-containing sites, with the
exception of the DR, in the rat (Figures S1P–S1V0) and mouse
(Figures S1W–S1AC0). Within the DR, leptin-induced pSTAT3
was absent from all 5-HT neurons in the rat (Figures 1C and
1C0, and Figures S1P–S1V0) and mouse (Figures 1D and 1D0,
and Figures S1W–S1AC0). In contrast, most DR Calb neurons
in the rat (Figures 1E and 1E0) and mouse (Figures 1F and 1F0)
contained leptin-induced pSTAT3, as did a subpopulation of
DR DA neurons in the rat (Figures S1N and S1N0) and mouse
(Figures S1O and S1O0). Thus, although some Calb- and
DA-expressing DR neurons contain functional LepRb, CNS
5-HT neurons do not.
Leptin Does Not Alter the Activity of DR 5-HT Neurons
We also examined the ability of leptin to influence the membrane
potential of identified DR 5-HT neurons in acute slice prepara-
tions from wild-type mice. We recorded from 26 DR neurons inCcurrent-clamp mode, after which recorded cells were filled
with biocytin and slices were subjected to the post hoc immuno-
histochemistry (IHC) identification of 5-HT. None (0/5) of the
recorded 5-HT-containing neurons demonstrated detectable
changes in membrane potential in response to leptin (Figures
2A–2C). Consistent with previous results from DR neurons not
characterized post hoc by IHC (Yadav et al., 2009), leptin
inhibited the firing of a subpopulation (29% [6/21]) of DR neurons
(Figures 2D–2F, p < 0.01). None of these leptin-responsive cells
were 5-HT positive (Figure 2F).
Yadav et al. reported increased expression of DR tryptophan
hydroxylase 2 (Tph2), which mediates 5-HT synthesis, in old,
but not young, Lepob/ob mice (Yadav et al., 2009), which
suggests that Tph2 expression changes in Lepob/ob mice are
related to age, rather than to direct leptin effects. Indeed, unlike
Yadav et al. (2009), we were not able to detect an effect of leptin
on DR Tph2 in wild-type mice, either by acute peripheral (0.5,
2.0, or 5.0 mg/kg, i.p.) or central (5 mg ICV) leptin treatment
(Figures S2A and S2B). Similarly, we were unable to detect
any changes in DR Tph2 in fasted rats receiving continuous
leptin treatment (a paradigm in which leptin induces changes in
other appetite-associated neuropeptides [Ahima et al., 1999])
(Figure S2C). Our data suggest that leptin does not directly or
significantly modulate DR Tph2 expression.ell Metabolism 13, 584–591, May 4, 2011 ª2011 Elsevier Inc. 585
Figure 2. Leptin Does Not Alter the Electrical Activity of DR 5-HT Neurons
(A) Representative firing trace of DR 5-HT cell in response to 500 nM leptin. Expanded traces highlight the firing rate before, during, and after application.
(B) Average firing rate of DR 5-HT cells before (control [cntr]) and after 500 nM leptin treatment; 100% (n = 5) of identified DR 5-HT neurons are unaffected by
500 nM leptin (mean ± SEM).
(C) Immunofluorescence imaging of the cell shown in (A), identified by biocytin staining (red); the cell contains 5-HT (green), overlay is shown in yellow.
(D) Representative firing trace of DR non-5-HT cell demonstrating an inhibitory response to 500 nM leptin. Expanded traces highlight the firing rate before, during,
and after application.
(E) Non-5-HT DR neurons inhibited by leptin, showing average firing rate before (control [cntr]) and after 500 nM leptin treatment (n = 6; mean ± SEM, **p < 0.01).
(F) Immunofluorescence imaging of the cell shown in (D), identified by biocytin staining (red); the cell does not contain 5-HT (green). Scale bar in (C) and (F), 30 mm.
See also Figure S2.
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Figure 3. Leptin-Induced Hypophagia Is Independent of Serotonin Bioavailability
Pretreatment with the tryptophan hydroxylase inhibitor PCPA (200 mg/kg i.p. twice daily for 3 days) (A) significantly depleted 5-HT (mean ± SEM) but did not
influence (B) DA (mean ± SEM) or (C) NA (mean ± SEM) in the brain (striatum [Str] and hypothalamus [Hypo] presented). Levels of neurotransmitters were
measured by HPLC. (D) This substantial 5-HT depletion did not impair leptin’s effects on 90min dark cycle food intake (n = 11 per treatment group, mean ± SEM).
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S3.
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of Serotonin Bioavailability
While leptin does not directly control CNS 5-HT neurons, we
investigated potential indirect interactions between 5-HT- and
LepRb-expressing cells using a transgenic mouse line in which
LepRb neurons throughout the brain express the transneuronal
tracer wheat germ agglutinin (Figure S3). Our observations indi-
cate that an unidentified population of LepRb neurons lie in
synaptic contact with DR 5-HT neurons (Figure S3).
In order to address the possibility of 5-HT participation in leptin
action via such an indirect mechanism, we utilized PCPA to
selectively deplete brain 5-HT, and by consequence its metabo-
lite 5-hydroxyindoleacetic acid, by80% (Figure 3A). Noradren-
aline (NA) and DA were not affected (Figures 3B and 3C). This
profound depletion of 5-HT did not interfere with the ability of
leptin (5 mg/kg, i.p.) to attenuate food intake (Figure 3D). Thus,
5-HT is not required for the anorectic action of leptin. These
data are consistent with the notion that leptin does not mediate
its effects on appetite via LepRb neurons synapsing on 5-HT
cells, and also with previous reports. Specifically, leptin exhibits
normal anorectic efficacy in mice null for 5-HT2CR (Nonogaki
et al., 1998), and mice null for both leptin and 5-HT2CR show
greater hyperphagia than mice with either mutation alone
(Wade et al., 2008). Furthermore, 5-HT requires themelanocortin
pathway to influence food intake, whereas leptin affects appetite
through both melanocortin-dependent and -independent path-
ways (Balthasar et al., 2004; Dhillon et al., 2006; Heisler et al.,
2002; Lam et al., 2008; Marsh et al., 1999). Thus, leptin’s effectsCon appetite and body weight are unlikely to be substantially 5-HT
dependent.
Deletion of LepRb from Sert-cre Neurons
Does Not Affect Body Weight
A recent paper by Yadav et al. reported that LepRb in 5-HT
neurons is crucial for most leptin action (Yadav et al., 2009).
Clearly, this conclusion is incompatible with the lack of LepRb/
5-HT coexpression, the lack of direct leptin effect on DR 5-HT
neurons, and the irrelevance of brain 5-HT content to the
anorexic action of leptin that we have demonstrated here. Meth-
odological factors may have promoted nonspecific signal in the
LepRb localization studies performed by Yadav et al., as their
depiction of LepRb abundance in the median raphe (MnR) as
well as the DR is not consistent with previous reports of LepRb
distribution (Elmquist et al., 1998; Patterson et al., 2011; Scott
et al., 2009).
Yadav et al. reported that mice lacking LepRb in 5-HT
transporter-cre (Sertcre)-expressing neurons are hyperphagic
and obese (Yadav et al., 2009). Sert is broadly expressed in
both 5-HT and non-5-HT neurons during development (Lebrand
et al., 1998; Narboux-Neme et al., 2008). We therefore in-
vestigated the possibility that the Sertcre eliminated LepRb
in crucial populations of non-5-HT neurons (Figure 4). We
crossed the Sertcre allele utilized by Yadav et al. onto the condi-
tional Leprfl background and the ROSA26-reporter alleles
that express EGFP/EYFP following cre-dependent excision
(Mao et al., 1999; McMinn et al., 2005; Narboux-Nemeell Metabolism 13, 584–591, May 4, 2011 ª2011 Elsevier Inc. 587
Figure 4. Characterization of Sertcre/LepRb Interaction
(A–C) Representative examples of immunofluorescent analysis of leptin-stimulated pSTAT3 (red) and Sertcre (GFP, green) in DR sections from Sertcre;ROSA26-
EGFP mice. (D–I) Representative analysis of immunohistochemical detection of ICV leptin-induced pSTAT3 in DR sections of control (D–F) and LeprSert mice
(G–I). (J–M) Body weight (8 weeks of age, J, mean ± SEM), gonadal fat pad weight (9 weeks of age, K, mean ± SEM), gonadal fat pad weight as a percentage
of body weight (L, mean ± SEM), and vertebral trabecular bone density (9 weeks of age, M, mean ± SEM) from male control (black bars) and LeprSert (hatched
bars) mice. (N) Genotyping of Lepr in three representative control (Leprfl/fl) and LeprSert mice compared to animals of known genotypes. Top panel, Lepr+ and
Leprfl bands; middle panel, LeprD; lower panel, multiplex analysis fails to distinguish Leprfl from LeprD. Scale bars in (C), (F), and (I), 100 mm. Insets are digital
enlargements. See also Figure S4.
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mediated recombination in non-5-HT neurons within the DR
and elsewhere in the brain (Figure S4).
We examined the potential colocalization of Sertcre-induced
EGFP with leptin-stimulated pSTAT3 in Sertcre;ROSA26-EGFP
mice (Figures 4A–4C); this revealed no colocalization of588 Cell Metabolism 13, 584–591, May 4, 2011 ª2011 Elsevier Inc.pSTAT3 with EGFP in the DR, although a few Sertcre/LepRb
neurons were observed in the LHA (Figure S4). Given the
modest number of Sertcre/LepRb neurons revealed by this anal-
ysis, we were surprised by the strong reported phenotype of
Sertcre;Leprfl/fl (LeprSert) mice (Yadav et al., 2009), and therefore
bred Sertcre;Leprfl/+ animals to independently derived Leprfl/fl
Cell Metabolism
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controls for analysis. Examination of leptin-stimulated pSTAT3
in the DR of control (Figures 4D–4F) and LeprSert (Figures 4G–
4I) animals revealed similar levels and patterns of leptin-
induced pSTAT3-IR in LeprSert and control animals, consistent
with the lack of Sertcre colocalization with LepRb in the DR. We
also examined the body weight and adiposity phenotypes of
LeprSert and littermate control animals (Figures 4J–4L). Body
and fat pad weights did not differ between LeprSert and control
animals, in contrast to the previously reported approximately
60% increase in body weight and 3- to 4-fold increase in fat
pad weight/body weight at similar ages (Yadav et al., 2009).
Vertebral bones from LeprSert mice were also similar to controls
(Figure 4M).
As the Leprfl allele is prone to germline excision in a number of
cre strains (generating the null LeprD allele) (van de Wall et al.,
2008, and our unpublished data), we thus examined the possi-
bility of such events in the LeprSert and littermate control animals
from Figure 4 (Figure 4N). While LeprD is not distinguished from
Leprfl by the standard three-primer multiplex genotyping para-
digm to detect Leprfl and Lepr (Figure 4N, bottom panel)
(McMinn et al., 2005), separation of the primer sets into two
reactions discerns Leprfl from the germline deleted (LeprD) allele
(Figure 4N, top and middle panels). Our analysis revealed
the presence of one germline-deleted LeprD allele in all of the
LeprSert mice that we examined (i.e., our LeprSert mice were
uniformly Sertcre;Leprfl/Dwhile controls were Leprfl/fl), suggesting
that germline deletion of Leprfl occurs uniformly in gametes
containing both Sertcre and Leprfl.
Given our present findings and the dramatic phenotype of the
LeprSertmice (closely resemblingmicecompletelydevoidof leptin
action) reported by Yadav et al., we surmise that this tendency
toward germline deletion combined with subsequent inbreeding
yielded LeprSert mice of the Sertcre;LeprD/D genotype (globally
Lepr deficient) in their hands. While the LeprSert animals studied
by Yadav et al. did not demonstrate overt diabetes as is often
observed inanimalsdevoidof LepRb, geneticbackgroundeffects
can suppress hyperglycemia in such animals, and this may have
been the case in the mixed genetic background animals studied
(Moritani et al., 2006; Yadav et al., 2009). With regards to the
more recent study inwhichLepRbwasdeleted in adults bymeans
of an inducible Tph2-cre (for which no recombination mapping
data were provided) (Yadav et al., 2011), we postulate ectopic
excision by this allele, given the substantial data demonstrating
the lack of LepRb expression in 5HT neurons and the failure of
Sertcre-mediated LepRb deletion to alter body energy balance.
Neuron-specific LepRb deletion data have revealed no single
pathway purported to mediate the majority of appetitive leptin
action, with the exception of the recently suggested 5-HT system
(Yadav et al., 2009, 2011). Here we clarify that brain 5-HT
neurons do not express LepRb and do not, therefore, directly
respond to leptin. Furthermore, our data reveal that brain 5-HT
is not required for the anorectic action of leptin, and that
neuron-specific excision of LepRb by Sertcre does not disrupt
DR leptin action or the ability of leptin to regulate energy homeo-
stasis. We conclude that leptin does not substantially influence
energy balance via brain 5-HT neurons, and that the crucial
population(s) of LepRb neurons for the control of energy balance
remains to be precisely identified.CEXPERIMENTAL PROCEDURES
Animals
LepRbEGFP mice were generated and propagated as previously described
(Leinninger et al., 2009). For studies with wild-type mice and rats, adult male
pathogen-free C57BL/6 mice (27–30 g) or Sprague-Dawley rats (250–300 g)
were used (Taconic or Charles River). All animals were individually housed
with water and chow pellets available ad libitum (unless otherwise stated) in
a light- (12 hr on/12 hr off) and temperature-controlled (21.5C–22.5C)
environment. Sertcre and Leprfl mice were the generous gifts of Xiaoxi Zhuang
(University of Chicago) and Streamson Chua (Albert Einstein College of
Medicine), respectively. ROSA26-EGFP and ROSA26-EYFP animals were
from the Jackson Laboratory. All procedures performed in the USA were in
accordance with National Institutes of Health (NIH) guidelines on animal care
and use and with the approval of the UCUCA; those performed in the UK
were approved by the UK Home Office.
Sertcre mice were genotyped via qPCR, using primers and probes for Cre
and Ngf, as described (Leinninger et al., 2009). Leprfl was genotyped by
conventional PCR (mLepR-105, mLepR-65A for Leprfl and Lepr+) in addition
to or in combination with mLepR-105 and mLepR-106 for LeprD (McMinn
et al., 2005).
Animal Perfusion and Immunohistochemistry
For pSTAT3 assessment in rats, femoral vein catheters were inserted as done
previously (Elias et al., 1998). Five days later, rats were injected with saline or
recombinant rat leptin (Sigma, 0.25 mg/kg or 1.0 mg/kg, i.v.) (n = 4 per dose).
For pSTAT3 assessment in C57BL/6 or Sertcre; reporter mice, saline or
recombinantmurine leptin (Peprotech or a generous gift of Amylin Pharmaceu-
ticals) was administered (n = 3/genotype). Animals were deeply anesthetized
and perfused transcardially with 0.9% saline followed by 10% formalin
(Sigma); brain tissue was collected as previously described (Elias et al.,
1998; Heisler et al., 2002; Leinninger et al., 2009; Munzberg et al., 2007) (see
the Supplemental Experimental Procedures for details).
For dual-label IHC, primary antibodies for pSTAT3 (1:250, rabbit, Cell
Signaling), GFP (1:1,000, rabbit, Molecular Probes or 1:000, chicken, Abcam),
5-HT (1:1,000, goat, Immunostar), Calb (1:500, mouse, Sigma), or TH (1:1,000,
mouse, Chemicon) were followed by secondary antibodies (Molecular Probes
and Jackson Immunoresearch): FITC-conjugated donkey anti-chicken (for
GFP, 1:200), Alexa Fluor 594 conjugated to donkey anti-goat (for 5-HT,
1:500), or Alexa Fluor 488 conjugated to donkey anti-mouse or anti-rabbit
(for Calb, TH, and GFP, 1:500).
Characterization of LeprSert Mice
For the analysis of LeprSert and control mice, 8-week-old male LeprSert (n = 9)
and control littermate (n = 5)mice were weighed. A subset of mice (LeprSert = 5,
control = 4) were implanted with ICV cannulae as described (Leinninger et al.,
2009). Coordinates to the lateral ventricle were, relative to Bregma, A/P0.34,
M/L 1.0, and D/V 2.4. For treatment, the dummy was replaced with an
injector to deliver 3 ml of PBS or leptin (1 mg/mL; Amylin Pharmaceuticals) at
a rate of 1 ml per minute. Mice were perfused 1 hr after treatment and brains
were sectioned and analyzed for pSTAT3 and GFP as described above.
Mice that were not cannulated were also perfused at 9 weeks of age. Gonadal
fat was dissected and weighed postperfusion. Analysis of vertebral bones was
carried out as described in the Supplemental Experimental Procedures.
5-HT Depletion and Leptin-Induced Hypophagia
Tryptophan hydroxylase inhibitor p-chlorophenylalanine (PCPA) treatment
was done as previously described (O’Leary et al., 2007). Briefly, mice
were treated with 200 mg/kg i.p. PCPA methyl ester hydrochloride (Sigma)
or water twice daily (at 9:00 am and 4:00 pm) for 3 days (n = 44). Mice
and food were weighed daily to ensure no adverse effect on body weight or
appetite. On the fourth day, mice received mouse recombinant leptin (Merck,
5 mg/kg, i.p.) or vehicle 120 min and 30 min prior to the onset of the dark
cycle (lights off at 7:00 pm) and food was removed. At the onset of the dark
cycle, food was returned and subsequent 90 min intake was assessed. On
completion of the study, animals were sacrificed (n = 11 per group) and brains
rapidly removed and frozen. Brains were sectioned coronally at 150 mm on
a cryostat and mounted onto glass slides. Micropunches were taken fromell Metabolism 13, 584–591, May 4, 2011 ª2011 Elsevier Inc. 589
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acid by an ultrasonic cell disruptor. Levels of 5-HT, 5-HIAA, DA, and NA in the
supernatant were determined by HPLC and electrochemical detection, as
described previously (Dalley et al., 2002).
Electrophysiology
Acute coronal brain slices (250 mm thick) containing the DR were prepared
from 22- to 44-day-old mice and standard whole-cell patch-clamp recordings
were performed (Burdakov and Ashcroft, 2002); see the Supplemental Exper-
imental Procedures. As in previous studies (Yadav et al., 2009), to facilitate the
firing of serotonin neurons, we supplemented aCSF (see the Supplemental
Experimental Procedures for details) with phenylephrine (3 mM, Tocris). The
following synaptic blockers were also added to aCSF: AP5 (50 mM), CNQX
(10 mM), picrotoxin (50 mM), strychnine (3 mM), and CGP52432 (10 mM) (Tocris).
Data collection and analysis were performed using Pulse (HEKA). To visualize
neurons after recordings, biocytin (0.5 mg/ml, Tocris) was added to the pipette
solution (see the Supplemental Experimental Procedures for details), and the
slices were fixed in 10% formalin. Immunohistochemical processing for the
detection of 5-HTwas performed as detailed above and images were acquired
using an Olympus BX61WI confocal microscope.
Data Analysis
The effect of drug treatment on cell firing rate was assessed using t test. The
effects of PCPA on 5-HT, 5-HIAA, DA, and NA levels in the striatum and hypo-
thalamus were analyzed with t test. The effect of PCPA pretreatment and leptin
treatment on food intake was assessed with a two-way ANOVA, followed by
Tukey HSD post hoc test. The effect of genotype on body weight, gonadal
fat, and bone density were analyzed with t test. For all analyses, significance
was assigned at the p% 0.05 level.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
at doi:10.1016/j.cmet.2011.03.016.
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